ImmuCell Corporation APIC, Share-based Payment Arrangement, Recognition and Exercise
ImmuCell Corporation (ICCC) reported APIC, Share-based Payment Arrangement, Recognition and Exercise of $184.50 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions · last filed 2016-11-10
- ImmuCell Corporation apic, share-based payment arrangement, recognition and exercise for the quarter ending 2016-09-30 was $0.00.
- ImmuCell Corporation apic, share-based payment arrangement, recognition and exercise for the quarter ending 2016-06-30 was $0.00.
- ImmuCell Corporation apic, share-based payment arrangement, recognition and exercise for the quarter ending 2016-03-31 was $184.50K.
| Period end | APIC, Share-based Payment Arrangement, Recognition and Exercise 3 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 6 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 9 month |
|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $184.50K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $184.50K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $184.50K 10-Q · filed 2016-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |